Overview
Periventricular nodular heterotopia (PVNH) is a neuronal migration disorder characterized by nodules of neurons located abnormally around the cerebral ventricles, often without associated neurological deficits but frequently linked to mutations in the FLNA gene. 1Diagnosis
Genetic Testing: Identification of FLNA mutations, particularly splice site mutations like c.1923C>T, is crucial for diagnosis 1.
Imaging: MRI is essential for visualizing characteristic periventricular nodules 1.
Clinical Features: Presence of facial dysmorphism and severe constipation may indicate a specific phenotype in males 1.
Neurological Examination: Typically normal in the absence of associated neurological abnormalities 1.Management
Symptomatic Treatment: Address constipation aggressively with appropriate pharmacological interventions (e.g., laxatives) 1.
Seizure Management: If epilepsy occurs, use antiepileptic drugs as needed (specific drug classes and doses not detailed in provided abstracts) 1.
Supportive Care: Focus on developmental support and monitoring for any emerging neurological issues 1.Special Populations
Pediatrics: Early genetic testing and MRI can aid in early diagnosis and management 1.
Comorbidities: Severe constipation requires specialized management, potentially indicating underlying molecular mechanisms 1.Key Recommendations
Perform genetic testing for FLNA mutations, especially splice site mutations, in diagnosing PVNH (Evidence: Moderate) 1
Utilize MRI for definitive imaging diagnosis of periventricular nodules (Evidence: Moderate) 1
Aggressively manage severe constipation in affected individuals, considering it a potential clue to underlying molecular pathology (Evidence: Weak) 1References
1 Hehr U, Hehr A, Uyanik G, Phelan E, Winkler J, Reardon W. A filamin A splice mutation resulting in a syndrome of facial dysmorphism, periventricular nodular heterotopia, and severe constipation reminiscent of cerebro-fronto-facial syndrome. Journal of medical genetics 2006. link